Management of Elevated PSA with Negative MRI and Moderate Prostate Hypertrophy

Clinical Significance of Laboratory Values

A PSA of 8.2 ng/mL falls within the 4.0-10.0 ng/mL range, where approximately 25-30% of men will have prostate cancer on biopsy 1, 2

While the MRI shows no evidence of tumor, it's essential to note that MRI has limitations in detecting small or low-grade prostate cancers 1
The trabeculation and transmural bladder wall thickening indicate bladder outlet obstruction from the enlarged prostate, which requires clinical attention regardless of cancer status 1

Transrectal ultrasound-guided biopsy with at least 10-12 core samples is the standard approach for patients with elevated PSA and negative MRI findings 1, 2
If initial biopsy is negative but PSA continues to rise, PSMA-PET/CT scan is recommended as it has higher sensitivity for detecting small prostate cancer foci than conventional imaging 1
Calculate PSA velocity (change over time) if previous values are available, and a rise of ≥0.75 ng/mL per year increases concern for cancer 2

If initial biopsy is negative, consider repeat PSA testing in 3-6 months to monitor trends 3
If biopsy confirms cancer, treatment options include radical prostatectomy for localized disease, radiation therapy, active surveillance for low-risk disease, and androgen deprivation therapy for more advanced disease 1